Akimasa Sanagawa

6PUBLICATIONS
10CO-AUTHORS
Predictive and prognostic markersMedical virologyCancer therapy (excl. chemotherapy and radiation therapy)Disease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 26, 2026
Perioperative Antifibrotic Treatment and Early Postoperative Outcomes in Patients With Idiopathic Pulmonary Fibrosis Undergoing Lung Cancer Surgery: A Systematic Review and Meta-Analysis.

|Feb 28, 2025
Increased Mitochondrial Superoxide Level Is Partially Associated With Vemurafenib-Induced Renal Tubular Toxicity.

Akimasa Sanagawa, Hiroshi Takase

|Jun 13, 2024
Effects of Body Mass Index on Hypertriglyceridemia Associated with Oral Bexarotene Therapy: A Post Hoc Analysis of an Open-Label Comparative Clinical Study of Combined Bexarotene and Phototherapy Versus Bexarotene Monotherapy for Japanese Patients with Cutaneous T-Cell Lymphoma.

Akimasa Sanagawa, Tomoaki Hayakawa, Aya Yamamoto

|Apr 12, 2023
Impact of body mass index on the severity of bexarotene-associated hypertriglyceridemia: A post hoc analysis of an open-labeled clinical study of combined bexarotene and phototherapy in Japanese patients with cutaneous T-cell lymphoma.

Akimasa Sanagawa, Tomoaki Hayakawa, Emi Nishida

|Aug 14, 2021
Influence of anticancer agents on sexual function: An in vivo study based on the US FDA Adverse Event Reporting System.

Tomoya Kataoka, Akimasa Sanagawa, Jun Suzuki

|Apr 18, 2018
Hepatitis B infection reported with cancer chemotherapy: analyzing the US FDA Adverse Event Reporting System.

Akimasa Sanagawa, Yuji Hotta, Tomoya Kataoka

Pageof 1

Frequent Collaborators

1 joint publications

Yuji Hotta

1 joint publications

Masahiro Tohkin

1 joint publications

Kazunori Kimura

1 joint publications

Tomoya Kataoka